Datta, D; Namazzi, R; Conroy, AL; Cusick, SE; Hume, HA; Tagoola, A; Ware, RE; Opoka, RO; John, CC.
Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS): study protocol for a randomized placebo-controlled trial in Ugandan children with sickle cell anemia.
Trials.
2019;
20.
Boucher, AA; Dong, M; Marahatta, A; Hausfeld, A; Howard, TA; Nathan, JD; Vinks, AA; McGann, PT; Ware, RE; Luchtman-Jones, L.
Hydroxyurea Pharmacokinetic Profiles in Children Treated for Extreme Thrombocytosis after Total Pancreatectomy with Islet Cell Autotransplant Demonstrate Poor Absorption.
Blood.
2019;
134:4893-4893.
Smart, LR; Ambrose, EE; Charles, M; Hernandez, AG; Latham, TS; Hokororo, A; Beyanga, M; Kamugisha, E; Tebuka, E; Howard, TA; et al.
Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants.
Blood.
2019;
134:988-988.
Henrici, RC; Sautter, C; Opoka, R; Namazzi, R; Park, GS; John, D; Conroy, AL; Ware, RE; John, CC.
Profound Alteration of Host Response in Severe Malarial Anemia By Sickle Cell Disease: Reduction of Parasite Sequestration and Inflammation, Upregulation of Angiopoietin-2.
Blood.
2019;
134:2283-2283.
George, A; Dinu, B; Estrada, N; Minard, C; Hurwitz, RL; Mahoney, D; Yates, AM; Vaughan, M; Carmouche, A; Airewele, G; et al.
Ndepth: A Randomized Controlled Trial of a Novel Dose-Prediction Equation to Determine Maximum Tolerated Dose for Hydroxyurea Therapy in Pediatric Patients with Sickle Cell Anemia.
Blood.
2019;
134:2267-2267.
Ware, RE; Brown, C; de Montalembert, M; Tonda, M; Tong, B; Hoppe, C; Lehrer-Graiwer, J; Abboud, MR.
Concomitant Hydroxyurea and Voxelotor: Results from the HOPE Study.
Blood.
2019;
134:1003-1003.
Ware, RE; Odame, I.
Newborn Screening With Sickle Cell Point of Care: A Valuable Resource in Low-Income Settings.
Pediatrics.
2019;
144.
Vichinsky, E; Hoppe, CC; Ataga, KI; Ware, RE; Nduba, V; El-Beshlawy, A; Hassab, H; Achebe, MM; Alkindi, S; Brown, RC; et al.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
New England Journal of Medicine.
2019;
381:509-519.
Ware, RE; McGann, PT; Quinn, CT.
Hydroxyurea for children with sickle cell anemia: Prescribe it early and often.
Pediatric Blood and Cancer.
2019;
66.
McGann, PT; Niss, O; Dong, M; Marahatta, A; Howard, TA; Mizuno, T; Lane, A; Kalfa, TA; Malik, P; Quinn, CT; et al.
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.
American Journal of Hematology.
2019;
94:871-879.
Kiyaga, C; Hernandez, AG; Ssewanyana, I; Schaefer, BA; McElhinney, KE; Ndeezi, G; Howard, TA; Ndugwa, CM; Ware, RE; Aceng, JR.
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
Pediatric Blood and Cancer.
2019;
66.
Yates, AM; Joshi, VM; Aygun, B; Moen, J; Smeltzer, MP; Govindaswamy, D; Dowdy, J; Cotton, A; Kang, G; Ware, RE; et al.
Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
Pediatric Blood and Cancer.
2019;
66.
Grace, RF; Ware, RE.
Pediatric Hematology.
Hematology/Oncology Clinics of North America.
2019;
33:xiii-xiv.
Vichinsky, E; Hoppe, CC; Ataga, KI; Ware, RE; Nduba, V; El Beshlawy, A; Hassab, H; Achebe, MM; Al-Kindi, S; Brown, C; et al.
S147 RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE.
HemaSphere.
2019;
3:25-26.
Grace, RF; Ware, RE.
Pediatric Hematology.
Hematology/Oncology Clinics of North America.
2019;
33.
Ware, RE; Thornburg, CD.
Your tired, your poor, your huddled masses.
Blood.
2019;
133:2010-2011.
Santos, B; Bernardino, L; Luis, J; da Fonseca, R; Nassesa, L; Andre, DA D O; Cuhna, L; Bengui, AF; de Oliveira, V; Tshilolo, L; et al.
Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
New England Journal of Medicine.
2019;
380:121-131.
Crosby, LE; Walton, A; Shook, LM; Ware, RE; Treadwell, M; Saving, KL; Britto, M; Peugh, J; McTate, E; Oyeku, S; et al.
Development of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell Anemia.
Journal of Pediatric Hematology/Oncology.
2019;
41:56-63.